New

Sickle Cell Disease Diagnosis Market

2021

Sickle Cell Disease Diagnosis Market Forecast to 2028 - COVID-19 Impact and Global Analysis By : Technology (Hemoglobin Electrophoresis, High-performance Liquid Chromatography (HPLC), Point-of-Care Tests, Other Tests); Age Group (Newborn Screening (12 months and below), Adult Screening (25 to 60 years), Other Age Groups (1 to 25 and above 60 years)); End User (Government Labs, Private Labs, Corporate Labs, PPP (Public-Private-Partnerships))

| Report Code: TIPRE00016807 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Market Insights

Sickle Cell Disease Diagnosis Market 2028 By : Technology, Age Group, End User | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Sickle cell disease is an inherited red blood cell disorder in which healthy red blood cells aren't enough to carry oxygen to all parts of the body. In this condition the red blood cells are sickles or crescent moons shape. Blood test is the most common type of diagnostic technique to detect sickle cell anemia. In the US, sickle cell disease blood test is part of routine newborn screening.

MARKET DYNAMICS

The key factors driving the growth of the sickle cell disease diagnosis market are increasing prevalence of sickle cell disease, increasing R&D activities to develop novel therapeutics, and newborn screening programs. However, lack of awareness about this disease and unavailability of diagnosis options in rural areas is likely to hamper the market growth during the forecast period.

MARKET SCOPE

The "Sickle Cell Disease Diagnosis Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of sickle cell disease diagnosis market with detailed market segmentation by technology, age group and end user. The sickle cell disease diagnosis market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in sickle cell disease diagnosis market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The sickle cell disease diagnosis market is segmented on the basis of technology, age group and end user. Based on technology, the market is segmented as hemoglobin electrophoresis, high-performance liquid chromatography (HPLC), point-of-care tests, other tests. The age group market is segmented into newborn screening (12 months and below), adult screening (25 to 60 years), and other age groups (1 to 25 and above 60 years). On the basis of end user, the market is categorized as government labs, private labs, corporate labs, PPP (Public-Private-Partnerships).

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the sickle cell disease diagnosis market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The sickle cell disease diagnosis market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting sickle cell disease diagnosis market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the sickle cell disease diagnosis market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the sickle cell disease diagnosis market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from sickle cell disease diagnosis market are anticipated to have lucrative growth opportunities in the future with the rising demand for sickle cell disease diagnosis in the global market. Below mentioned is the list of few companies engaged in the sickle cell disease diagnosis market.

The report also includes the profiles of key players in sickle cell disease diagnosis market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

    1. STRECK
    2. BIOMEDOMICS INC.
    3. Hemex Health
    4. Silver Lake Research Corporation
    5. Laboratory Corporation of America Holdings
    6. Quest Diagnostics Incorporated
    7. HALCYON BIOMEDICAL INCORPORATED
    8. PerkinElmer Inc.
    9. Bio-Rad Laboratories, Inc.
    10. Daktari Diagnostics

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Sickle Cell Disease Diagnosis Market - By Technology
1.3.2 Sickle Cell Disease Diagnosis Market - By Age Group
1.3.3 Sickle Cell Disease Diagnosis Market - By End User
1.3.4 Sickle Cell Disease Diagnosis Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SICKLE CELL DISEASE DIAGNOSIS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SICKLE CELL DISEASE DIAGNOSIS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SICKLE CELL DISEASE DIAGNOSIS MARKET - GLOBAL MARKET ANALYSIS
6.1. SICKLE CELL DISEASE DIAGNOSIS - GLOBAL MARKET OVERVIEW
6.2. SICKLE CELL DISEASE DIAGNOSIS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. SICKLE CELL DISEASE DIAGNOSIS MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. HEMOGLOBIN ELECTROPHORESIS
7.3.1. Overview
7.3.2. Hemoglobin Electrophoresis Market Forecast and Analysis
7.4. HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC)
7.4.1. Overview
7.4.2. High-performance Liquid Chromatography (HPLC) Market Forecast and Analysis
7.5. POINT-OF-CARE TESTS
7.5.1. Overview
7.5.2. Point-of-Care Tests Market Forecast and Analysis
7.6. OTHER TESTS
7.6.1. Overview
7.6.2. Other Tests Market Forecast and Analysis
8. SICKLE CELL DISEASE DIAGNOSIS MARKET - REVENUE AND FORECASTS TO 2028 - AGE GROUP
8.1. OVERVIEW
8.2. AGE GROUP MARKET FORECASTS AND ANALYSIS
8.3. NEWBORN SCREENING (12 MONTHS AND BELOW)
8.3.1. Overview
8.3.2. Newborn Screening (12 months and below) Market Forecast and Analysis
8.4. ADULT SCREENING (25 TO 60 YEARS)
8.4.1. Overview
8.4.2. Adult Screening (25 to 60 years) Market Forecast and Analysis
8.5. OTHER AGE GROUPS (1 TO 25 AND ABOVE 60 YEARS)
8.5.1. Overview
8.5.2. Other Age Groups (1 to 25 and above 60 years) Market Forecast and Analysis
9. SICKLE CELL DISEASE DIAGNOSIS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. GOVERNMENT LABS
9.3.1. Overview
9.3.2. Government Labs Market Forecast and Analysis
9.4. PRIVATE LABS
9.4.1. Overview
9.4.2. Private Labs Market Forecast and Analysis
9.5. CORPORATE LABS
9.5.1. Overview
9.5.2. Corporate Labs Market Forecast and Analysis
9.6. PPP (PUBLIC-PRIVATE-PARTNERSHIPS)
9.6.1. Overview
9.6.2. PPP (Public-Private-Partnerships) Market Forecast and Analysis
10. SICKLE CELL DISEASE DIAGNOSIS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Sickle Cell Disease Diagnosis Market Overview
10.1.2 North America Sickle Cell Disease Diagnosis Market Forecasts and Analysis
10.1.3 North America Sickle Cell Disease Diagnosis Market Forecasts and Analysis - By Technology
10.1.4 North America Sickle Cell Disease Diagnosis Market Forecasts and Analysis - By Age Group
10.1.5 North America Sickle Cell Disease Diagnosis Market Forecasts and Analysis - By End User
10.1.6 North America Sickle Cell Disease Diagnosis Market Forecasts and Analysis - By Countries
10.1.6.1 United States Sickle Cell Disease Diagnosis Market
10.1.6.1.1 United States Sickle Cell Disease Diagnosis Market by Technology
10.1.6.1.2 United States Sickle Cell Disease Diagnosis Market by Age Group
10.1.6.1.3 United States Sickle Cell Disease Diagnosis Market by End User
10.1.6.2 Canada Sickle Cell Disease Diagnosis Market
10.1.6.2.1 Canada Sickle Cell Disease Diagnosis Market by Technology
10.1.6.2.2 Canada Sickle Cell Disease Diagnosis Market by Age Group
10.1.6.2.3 Canada Sickle Cell Disease Diagnosis Market by End User
10.1.6.3 Mexico Sickle Cell Disease Diagnosis Market
10.1.6.3.1 Mexico Sickle Cell Disease Diagnosis Market by Technology
10.1.6.3.2 Mexico Sickle Cell Disease Diagnosis Market by Age Group
10.1.6.3.3 Mexico Sickle Cell Disease Diagnosis Market by End User
10.2. EUROPE
10.2.1 Europe Sickle Cell Disease Diagnosis Market Overview
10.2.2 Europe Sickle Cell Disease Diagnosis Market Forecasts and Analysis
10.2.3 Europe Sickle Cell Disease Diagnosis Market Forecasts and Analysis - By Technology
10.2.4 Europe Sickle Cell Disease Diagnosis Market Forecasts and Analysis - By Age Group
10.2.5 Europe Sickle Cell Disease Diagnosis Market Forecasts and Analysis - By End User
10.2.6 Europe Sickle Cell Disease Diagnosis Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Sickle Cell Disease Diagnosis Market
10.2.6.1.1 Germany Sickle Cell Disease Diagnosis Market by Technology
10.2.6.1.2 Germany Sickle Cell Disease Diagnosis Market by Age Group
10.2.6.1.3 Germany Sickle Cell Disease Diagnosis Market by End User
10.2.6.2 France Sickle Cell Disease Diagnosis Market
10.2.6.2.1 France Sickle Cell Disease Diagnosis Market by Technology
10.2.6.2.2 France Sickle Cell Disease Diagnosis Market by Age Group
10.2.6.2.3 France Sickle Cell Disease Diagnosis Market by End User
10.2.6.3 Italy Sickle Cell Disease Diagnosis Market
10.2.6.3.1 Italy Sickle Cell Disease Diagnosis Market by Technology
10.2.6.3.2 Italy Sickle Cell Disease Diagnosis Market by Age Group
10.2.6.3.3 Italy Sickle Cell Disease Diagnosis Market by End User
10.2.6.4 Spain Sickle Cell Disease Diagnosis Market
10.2.6.4.1 Spain Sickle Cell Disease Diagnosis Market by Technology
10.2.6.4.2 Spain Sickle Cell Disease Diagnosis Market by Age Group
10.2.6.4.3 Spain Sickle Cell Disease Diagnosis Market by End User
10.2.6.5 United Kingdom Sickle Cell Disease Diagnosis Market
10.2.6.5.1 United Kingdom Sickle Cell Disease Diagnosis Market by Technology
10.2.6.5.2 United Kingdom Sickle Cell Disease Diagnosis Market by Age Group
10.2.6.5.3 United Kingdom Sickle Cell Disease Diagnosis Market by End User
10.2.6.6 Rest of Europe Sickle Cell Disease Diagnosis Market
10.2.6.6.1 Rest of Europe Sickle Cell Disease Diagnosis Market by Technology
10.2.6.6.2 Rest of Europe Sickle Cell Disease Diagnosis Market by Age Group
10.2.6.6.3 Rest of Europe Sickle Cell Disease Diagnosis Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Sickle Cell Disease Diagnosis Market Overview
10.3.2 Asia-Pacific Sickle Cell Disease Diagnosis Market Forecasts and Analysis
10.3.3 Asia-Pacific Sickle Cell Disease Diagnosis Market Forecasts and Analysis - By Technology
10.3.4 Asia-Pacific Sickle Cell Disease Diagnosis Market Forecasts and Analysis - By Age Group
10.3.5 Asia-Pacific Sickle Cell Disease Diagnosis Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Sickle Cell Disease Diagnosis Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Sickle Cell Disease Diagnosis Market
10.3.6.1.1 Australia Sickle Cell Disease Diagnosis Market by Technology
10.3.6.1.2 Australia Sickle Cell Disease Diagnosis Market by Age Group
10.3.6.1.3 Australia Sickle Cell Disease Diagnosis Market by End User
10.3.6.2 China Sickle Cell Disease Diagnosis Market
10.3.6.2.1 China Sickle Cell Disease Diagnosis Market by Technology
10.3.6.2.2 China Sickle Cell Disease Diagnosis Market by Age Group
10.3.6.2.3 China Sickle Cell Disease Diagnosis Market by End User
10.3.6.3 India Sickle Cell Disease Diagnosis Market
10.3.6.3.1 India Sickle Cell Disease Diagnosis Market by Technology
10.3.6.3.2 India Sickle Cell Disease Diagnosis Market by Age Group
10.3.6.3.3 India Sickle Cell Disease Diagnosis Market by End User
10.3.6.4 Japan Sickle Cell Disease Diagnosis Market
10.3.6.4.1 Japan Sickle Cell Disease Diagnosis Market by Technology
10.3.6.4.2 Japan Sickle Cell Disease Diagnosis Market by Age Group
10.3.6.4.3 Japan Sickle Cell Disease Diagnosis Market by End User
10.3.6.5 South Korea Sickle Cell Disease Diagnosis Market
10.3.6.5.1 South Korea Sickle Cell Disease Diagnosis Market by Technology
10.3.6.5.2 South Korea Sickle Cell Disease Diagnosis Market by Age Group
10.3.6.5.3 South Korea Sickle Cell Disease Diagnosis Market by End User
10.3.6.6 Rest of Asia-Pacific Sickle Cell Disease Diagnosis Market
10.3.6.6.1 Rest of Asia-Pacific Sickle Cell Disease Diagnosis Market by Technology
10.3.6.6.2 Rest of Asia-Pacific Sickle Cell Disease Diagnosis Market by Age Group
10.3.6.6.3 Rest of Asia-Pacific Sickle Cell Disease Diagnosis Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Sickle Cell Disease Diagnosis Market Overview
10.4.2 Middle East and Africa Sickle Cell Disease Diagnosis Market Forecasts and Analysis
10.4.3 Middle East and Africa Sickle Cell Disease Diagnosis Market Forecasts and Analysis - By Technology
10.4.4 Middle East and Africa Sickle Cell Disease Diagnosis Market Forecasts and Analysis - By Age Group
10.4.5 Middle East and Africa Sickle Cell Disease Diagnosis Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Sickle Cell Disease Diagnosis Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Sickle Cell Disease Diagnosis Market
10.4.6.1.1 South Africa Sickle Cell Disease Diagnosis Market by Technology
10.4.6.1.2 South Africa Sickle Cell Disease Diagnosis Market by Age Group
10.4.6.1.3 South Africa Sickle Cell Disease Diagnosis Market by End User
10.4.6.2 Saudi Arabia Sickle Cell Disease Diagnosis Market
10.4.6.2.1 Saudi Arabia Sickle Cell Disease Diagnosis Market by Technology
10.4.6.2.2 Saudi Arabia Sickle Cell Disease Diagnosis Market by Age Group
10.4.6.2.3 Saudi Arabia Sickle Cell Disease Diagnosis Market by End User
10.4.6.3 U.A.E Sickle Cell Disease Diagnosis Market
10.4.6.3.1 U.A.E Sickle Cell Disease Diagnosis Market by Technology
10.4.6.3.2 U.A.E Sickle Cell Disease Diagnosis Market by Age Group
10.4.6.3.3 U.A.E Sickle Cell Disease Diagnosis Market by End User
10.4.6.4 Rest of Middle East and Africa Sickle Cell Disease Diagnosis Market
10.4.6.4.1 Rest of Middle East and Africa Sickle Cell Disease Diagnosis Market by Technology
10.4.6.4.2 Rest of Middle East and Africa Sickle Cell Disease Diagnosis Market by Age Group
10.4.6.4.3 Rest of Middle East and Africa Sickle Cell Disease Diagnosis Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Sickle Cell Disease Diagnosis Market Overview
10.5.2 South and Central America Sickle Cell Disease Diagnosis Market Forecasts and Analysis
10.5.3 South and Central America Sickle Cell Disease Diagnosis Market Forecasts and Analysis - By Technology
10.5.4 South and Central America Sickle Cell Disease Diagnosis Market Forecasts and Analysis - By Age Group
10.5.5 South and Central America Sickle Cell Disease Diagnosis Market Forecasts and Analysis - By End User
10.5.6 South and Central America Sickle Cell Disease Diagnosis Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Sickle Cell Disease Diagnosis Market
10.5.6.1.1 Brazil Sickle Cell Disease Diagnosis Market by Technology
10.5.6.1.2 Brazil Sickle Cell Disease Diagnosis Market by Age Group
10.5.6.1.3 Brazil Sickle Cell Disease Diagnosis Market by End User
10.5.6.2 Argentina Sickle Cell Disease Diagnosis Market
10.5.6.2.1 Argentina Sickle Cell Disease Diagnosis Market by Technology
10.5.6.2.2 Argentina Sickle Cell Disease Diagnosis Market by Age Group
10.5.6.2.3 Argentina Sickle Cell Disease Diagnosis Market by End User
10.5.6.3 Rest of South and Central America Sickle Cell Disease Diagnosis Market
10.5.6.3.1 Rest of South and Central America Sickle Cell Disease Diagnosis Market by Technology
10.5.6.3.2 Rest of South and Central America Sickle Cell Disease Diagnosis Market by Age Group
10.5.6.3.3 Rest of South and Central America Sickle Cell Disease Diagnosis Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL SICKLE CELL DISEASE DIAGNOSIS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. SICKLE CELL DISEASE DIAGNOSIS MARKET, KEY COMPANY PROFILES
13.1. STRECK
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BIOMEDOMICS INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. HEMEX HEALTH
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. SILVER LAKE RESEARCH CORPORATION
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. LABORATORY CORPORATION OF AMERICA HOLDINGS
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. QUEST DIAGNOSTICS INCORPORATED
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. HALCYON BIOMEDICAL INCORPORATED
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. PERKINELMER INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. BIO-RAD LABORATORIES, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. DAKTARI DIAGNOSTICS.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. STRECK
2. BIOMEDOMICS INC.
3. Hemex Health
4. Silver Lake Research Corporation
5. Laboratory Corporation of America Holdings
6. Quest Diagnostics Incorporated
7. HALCYON BIOMEDICAL INCORPORATED
8. PerkinElmer Inc.
9. Bio-Rad Laboratories, Inc.
10. Daktari Diagnostics.
TIPRE00016807
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.